EUVIMEDEUVIMED entdecken
Crossref

Intravitreal bevacizumab (Avastin) with peripheral retinal cryotherapy for patients with posterior retinopathy of prematurity and vitreous hemorrhage

MohammadM. K. Diab

Journal of the Egyptian Ophthalmological Society · 2013

DOI: 10.4103/2090-0686.127351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the Egyptian Ophthalmological Society, 2013. Verfasst von MohammadM. K. Diab.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PurposeTo report the short-term anatomic response of intravitreal bevacizumab (Avastin) and peripheral cryotherapy for the treatment of posterior retinopathy of prematurity (ROP) with vitreous hemorrhage in a small series of patients.Patients and methodsThis was a retrospective study that included 19 eyes of 14 premature babies with posterior ROP and vitreous hemorrhage in whom conventional laser treatment could not be applied. Patients received an intravitreal injection of bevacizumab (Avastin) together with peripheral retinal cryotherapy.ResultsVascularization began to regress within a few days after the injection, but vitreous hemorrhage absorbed more slowly. Repeat intravitreal injections of bevacizumab were administered in eight eyes within 1 month from the first injection. There were varying development of tractional retinal detachments in two of the eyes, but the ROP component quieted in all cases.ConclusionOff-label use of intravitreal bevacizumab with peripheral retinal cryotherapy appears to be useful as a treatment for posterior ROP when laser treatment is precluded. It improves dilatation, regressing and quiescent the disease, and improves visibility.

Zitieren

APA

Diab, M. K. (2013). Intravitreal bevacizumab (Avastin) with peripheral retinal cryotherapy for patients with posterior retinopathy of prematurity and vitreous hemorrhage. Journal of the Egyptian Ophthalmological Society. https://doi.org/10.4103/2090-0686.127351

Vancouver

Diab MK. Intravitreal bevacizumab (Avastin) with peripheral retinal cryotherapy for patients with posterior retinopathy of prematurity and vitreous hemorrhage. Journal of the Egyptian Ophthalmological Society. 2013. doi:10.4103/2090-0686.127351

BibTeX
@article{Diab2013,
  author = {Diab, MohammadM. K.},
  title = {Intravitreal bevacizumab (Avastin) with peripheral retinal cryotherapy for patients with posterior retinopathy of prematurity and vitreous hemorrhage},
  journal = {Journal of the Egyptian Ophthalmological Society},
  year = {2013},
  doi = {10.4103/2090-0686.127351}
}
Kostenlos starten →